Table 3 Angiographic characteristics of the restenosis and procedural results of in-stent restenosis-treated patients with paclitaxel-coated balloon angioplasty or drug-eluting stent
PCB% (n = 32) | DES% (n = 51) | p value | |
|---|---|---|---|
Pre-procedure | |||
Focal | 34.4% (11) | 27.4% (14) | 0.48 |
Diffuse | 40.6% (13) | 37.2% (19) | 0.57 |
Proliferative | 9.4% (3) | 29.6% (10) | 0.38 |
Total occlusive | 15.6% (5) | 15.7% (8) | 0.71 |
Lesion length (mm) | 22.5 ± 7.9 | 24.2 ± 12.7 | 0.36 |
Reference vessel diameter (mm) | 2.7 ± 0.4 | 2.7 ± 0.57 | 0.61 |
Used device length (mm) | 19.75 ± 5.7 | 22.1 ± 16.5 | < 0.001 |
Used device diameter (mm) | 3.1 ± 0.34 | 2.9 ± 0.84 | 0.64 |
Minimal lumen diameter (mm) | 0.93 ± 069 | 0.92 ± 0.59 | 0.80 |
Diameter Stenosis (%) | 66.4 ± 12.4 | 67.9 ± 17.4 | 0.78 |
Post-procedure | |||
Minimal lumen diameter (mm) | 2.26 ± 0.55 | 2.5 ± 0.4 | 0.20 |
Acute lumen gain (mm) | 1.3 ± 0.75 | 1.6 ± 0.61 | 0.16 |